Pregled bibliografske jedinice broj: 890604
The evidence for clinically significant bias in plasma glucose between liquid and lyophilized citrate buffer additive
The evidence for clinically significant bias in plasma glucose between liquid and lyophilized citrate buffer additive // Clinical biochemistry, 49 (2016), 18; 1402-1405 doi:10.1016/j.clinbiochem.2016.03.006 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 890604 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
The evidence for clinically significant bias in plasma glucose between liquid and lyophilized citrate buffer additive
Autori
Juričić, Gordana ; Saračević, Andrea ; Milevoj Kopčinović, Lara ; Bakliža, Ana ; Šimundić, Ana- Maria
Izvornik
Clinical biochemistry (0009-9120) 49
(2016), 18;
1402-1405
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
Diabetes ; Glucomedics ; Glycolysis inhibitors ; Preanalytical phase ; Venosafe Glycemia
Sažetak
Citrate buffer additive has been suggested to be of supreme performance in inhibiting glycolysis. However, there is little evidence in the literature regarding the comparability of glucose concentrations in liquid and lyophilized citrate buffer containing tubes. The aim of this study was to compare glucose concentrations in tubes containing liquid (Glucomedics) and lyophilized citrate buffer (Terumo VENOSAFE™ Glycemia) additive, measured immediately after centrifugation.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti, Farmacija
POVEZANOST RADA
Ustanove:
Farmaceutsko-biokemijski fakultet, Zagreb,
Klinička bolnica "Sveti Duh",
KBC "Sestre Milosrdnice",
Opća bolnica Pula,
Psihijatrijska bolnica "Sveti Ivan" Zagreb
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE
